EUR 162.24 For Business Accounts Only

Surgical Specialties Corp Inc - Strategy, SWOT and Corporate Finance Report

Synopsis

Surgical Specialties Corp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Summary

- Detailed information on Surgical Specialties Corp Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Surgical Specialties Corp Inc in the form of a SWOT analysis
- An in-depth view of the business model of Surgical Specialties Corp Inc including a breakdown and examination of key business segments
- Intelligence on Surgical Specialties Corp Inc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Surgical Specialties Corp Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

- Gain understanding of Surgical Specialties Corp Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Surgical Specialties Corp Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Surgical Specialties Corp Inc's business structure, strategy and prospects.

Key Highlights

Surgical Specialties Corporation (Surgical Specialties or 'the company), formerly known as Angiotech Pharmaceuticals, is a medical devices company engaged in the development, manufacturing and marketing of surgical instruments for its own brands. The company operates in the US, Canada, and Europe. It is headquartered in Vancouver, Canada.